Search clinical trials for: Ibritumomab Tiuxetan

Total 106 results

Lund University Hospital
Bayer

Completed

High Dose, Absorbed Dose Adjusted 90Y-ibritumomab With Peripheral Blood Stem Cells (PBSC) Support in B-cell Lymphoma (HITT)

B-cell Lymphoma

Sweden
National Cancer Institute (NCI)

Completed

Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Anaplastic Large Cell Lymphoma

United States
Novartis Pharmaceuticals

Completed

EPO906 Therapy in Patients With Advanced Colorectal Cancer

Colorectal Neoplasms | Colonic Neoplasms

United States
Novartis Pharmaceuticals

Completed

EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer

Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms

Netherlands, Canada, United States, Slovakia, United Kingdom
Pfizer

Completed

Anidulafungin In Treatment Of Candidemia In Asian Subjects

Candidemia

Taiwan, India, Thailand, Philippines
Institut National de la Santé Et de la Recherche...
Assistance Publique - Hôpitaux de Paris; Ministry of Health, France; Ministry...

Terminated

Comparison of Two Pharmacological Treatments of Pedophilia (PCNET)

Pedophilia

France

3

Subscribe